Научные статьиM.H.Sayidova, S.U.Pulatova2025
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
Reed F. Beall · Jason W. Nickerson · Warren A. Kaplan
Научные статьи · 2016
Аннотация
Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement. This phenomenon, pejoratively known as “evergreening”, can allow manufacturers to preserve market exclusivity, but without significantly bettering the standard of care. Other studies speculate that evergreening is especially problematic for medicine/device combination products, because patents on the device component may outlast expired patents on the medicine component, and thereby keep competing, possibly lessexpensive generic products off the market.
Доказательный фрагмент
«Not all new drug products are truly new.»
Образец извлечения
Демо-превьюNot all new drug products are truly new. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
Смежные источники
Общество и инновацииKhosiyat MAMATKULOVA2024
Академические исследования в современной наукеKhudaiberdiyeva Arafat Israilovna, Ph.D Professor hudayberdiyevaarofat@gmail.com +12026
Научные статьиI.B.Yangiboyev, E.X.Berdanov +22025